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Immediately after a lethal dose of endotoxin is injected intravenously into the 
dog, there is an abrupt onset of hypotension that is related to the pooling of 
blood in the liver and in the intestine  (1).  Congestion of the liver is associated 
with spasm of the hepatic venous system, and this can be correlated with an 
increase in  the concentration of histamine in the hepatic vein (2).  The most 
significant initial feature in the chain of hemodynamic alterations occurring in 
endotoxin shock is a marked vasoconstriction. 
This report is concerned with studies  on the initial  effects of endotoxin on 
the vascular beds of the dog. As a preliminary step, in vitro experiments were 
carried out with isolated, canine, saphenous veins suspended in an oxygenated 
bath (3).  The vessels  were exposed to each of several physiologic solutions and 
endotoxin, and contraction took place only in the presence of fresh whole blood 
and endotoxin. A heat-labile serum or plasma factor, inactivated by heating at 
56°C  for  30 minutes,  was essential.  Vessel  contraction induced by liberated 
histamine resulted from the interaction  of endotoxin, fresh serum or plasma, 
and platelets.  These results  were extended to the intact animal,  and the fol- 
lowing  experiments  demonstrate  that  the  initiation  of  the  hemodynamic 
changes in endotoxin shock is dependent upon the interaction of a labile serum 
factor and endotoxin. The results suggest that  an enzyme system may be  in- 
volved in the initial stage of this type of shock. 
Materials and Methods 
A total of 78 adult mongrel dogs were used in five experimental studies. The dogs were 
anesthetized with Na pentobarbital (30 mg/kg). A standardized lethal dose of 0.55 mg/kg of 
Escherichia coli endotoxin was used throughout, prepared in a manner previously described 
(4). Hemodynamie  alterations were measured over a period of 8 hours, and included continu- 
ous tracings of systemic blood pressure, and hourly recordings of blood pH and hematocrit 
values (5). Dogs were recorded as "survivors" if they lived 72 hours or longer postendotoxin. 
Group  1 Experiments.--Ten control anesthetized animals were given the  standardized 
lethal dose of endotoxin intravenously, and continuously observed for 8 hours, or until the 
animals expired. 
Group 2 Experiments.--Blood was removed from the femoral artery of each of 10 donor 
animals and collected in sterile flasks containing 1 mg of heparin per 100 cc of blood. Immedi- 
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ately after withdrawal, plasma was separated from the cells under sterile conditions by centri- 
fuging for 30 minutes at 1500 Rv~t. The blood was then reconstituted, warmed to body tem- 
perature, and infused into the femoral vein of a normal recipient animal, while an equivalent 
amount of blood was withdrawn from the contralateral femoral artery. Each dog received an 
average of 602 cc of reconstituted blood obtained from one donor. Mter the transfusion had 
been completed, there was an equilibration period of 1 hour, after which the lethal dose of 
endotoxin was intravenously administered. 
Group 3 Experiments.--Blood was obtained from 10 donor animals in the same manner as 
described for the preceding group, centrifuged, reconstituted, and infused into 10 recipients. 
The essential difference in these experiments was that the donor plasma was heated for 30 
minutes  at  56°C before the blood was reconstituted  and  transfused  into normal  animals. 
Each dog received an average of 580 cc of blood. 
Group 4 Experiments.--This group included 7 normal dogs that had been transfused  with 
heparinized blood obtained from 7 donor animals treated in the following manner: each of the 
donors,  under a protective regime described elsewhere (5-7),  had survived a  lethal dose of 
endotoxin. These animals were resistant to a lethal dose of endotoxin given 8 days after the 
initial dose. Within 24 hours after receiving th~ second dose of endotoxin, blood was withdrawn 
from  these  immune  donors  and transfused into each of the  7 normal  animals.  As in  the 
previous experiments the same amount of blood was withdrawn from the recipient dogs as 
the amount infused.  Each animal received an average of 340  cc of heparinized blood. Mter 
an equilibration period of 1 hour, each of the recipients was given 0.55  mg/kg of endotoxin. 
Group 5 Experiments.--Tlfis group comprised 7 normal animals that had received hepari- 
nized whole blood under the same conditions as the animals in group 4, except the blood  from 
the donor animals was not withdrawn until 72 hours after the second dose of endotoxin. In other 
words,  animals in group 4 received blood from endotoxin-resistant donors that had been with- 
drawn within 24 hours after a  second injection of endotoxin, while animals in the present 
group received blood from resistant donors that had been withdrawn 72 hours after the second 
injection. Each of the recipient animals received an average of 318 cc of blood. The purpose of 
the experiments in groups 4 and 5 was to determine if the amount of serum factor essential 
for endotoxin shock had  been depleted for a  given period of time, i.e. 24 hours,  and if an 
elapse of 3 days or more was sufficient for the reappearance of enough serum factor to react 
with endotoxin and cause peripheral vascular collapse and  death. 
RESULTS 
Group 1 Experiments.  Endotoxin Shock in Control  Animals.--Data  recorded 
in  Table  I  show  that  all  the  animals  expired.  Postendotoxin  survival  times 
ranged from 30 minutes  to 28 hours.  The characteristic features  of irreversible 
endotoxin shock,  as detailed  elsewhere,  were present  and  included progressive 
hypotension,  oliguria and anuria,  hemoconcentration,  and acidosis  (7). 
Group 2 Experiments. Dogs Transfused with Unheated Plasma in Reconstituted 
Blood and Given Endotoxin.--As seen in Table II there were only 2 survivors of 
the 10 animals treated in this manner. All of the animals, except the 2 survivors, 
exhibited the usual pattern of progressive endotoxin shock. 
Group 3  Experiments.  Dogs  Transfused with Reconstituted Blood Containing 
Plasma Heated to 56°C for 30 Minutes and then Given Endotoxin.--In  contrast 
with the outcome in control animals (Table I), and animals transfused with re- 
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average of 580 cc reconstituted heated blood survived a lethal dose of endotoxin 
(Table III). All of the animals in the latter group displayed a  decline in blood 
pressure immediately following the injection of endotoxin. Except for  1 non- 
TABLE I 
Sureival  Time of Dogs Given 0.55 Mg per Kg of E. Coli Endotoxin 
Dog'~No.  Weight  Sex  Survival  time 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
kg 
5.5 
9.5 
8.2 
5.7 
9.4 
10.2 
6.1 
7.0 
11.0 
7.3 
F 
M 
M 
M 
F 
F 
F 
M 
M 
F 
30 min. 
48  " 
16 hrs. 
28  " 
18  " 
18  " 
7  " 
10  " 
12  " 
18  " 
TABLE II 
Survival  Time  of  Control  Dogs  Given  Transfusion  of  Whole  Blood  Reconstituted  after 
Centrifugation  with Unheated  Plasma, and  Then Injected with 0.55  Mg per Kg of 
E. coli  Endotoxin 
Dog No.  Weight  Sex  Amount of blood  Survival time 
infused 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
kg 
7.0 
7.5 
7.0 
7.6 
4.8 
5.4 
9.0 
6.4 
4.1 
6.5 
F 
M 
M 
M 
F 
F 
F 
F 
M 
F 
GG 
621 
612 
6O5 
610 
532 
590 
737 
600 
516 
60O 
hrs. 
6 
16 
40 
Permanent 
16 
2.5 
3 
62 
16 
Average.  602  13 
survivor,  the  blood  pressure  became  stabilized  within  2  to  3  hours  post 
endotoxin. Hemoconcentration occurred in only 2 of the survivors and acidosis 
as measured by blood pH was not demonstrated in any of the animals. It is 
significant that this group of animals tolerated a large dose of endotoxin better 
than any group in our experience, including those given a lethal dose of endo- 504  LABILE  SERUM  FACTOR IN  ENDOTOXIN  SHOCK 
toxin, and then protected with steroids, pressor agents,  hydralazine  or  epsilon 
aminocaproic  acid  (5-7). 
TABLE III 
Survival Time of Dogs Given Transfusion  of Whole Blood Reconstituted after Centrifugation 
with Plasma Heated to 56°Clot 30 Minutes and Then Injected with 0.55 Mg per Kg of 
E. coli Endotoxin 
Amount of blood  Dog No.  Weight  Sex  infused  Survival time 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Average.. 
kg 
8.9 
7.4 
6.7 
8.0 
9.0 
7.5 
8.4 
8.0 
5.0 
6.7 
F 
M 
F 
M 
F 
F 
M 
M 
F 
M 
cc 
623 
550 
578 
435 
583 
605 
660 
620 
620 
523 
580 
hrs. 
Permanent 
~t 
20 
Permanent 
TABLE IV 
Survival Time of Dogs Given Infusion  of Whole Blood 
Donor  blood  obtained  from  animals  8  days  after  recovery from  endotoxin  shock  and 
immediately after second injection of E. coli endotoxin. 
Dog No.  Amount of blood  Survival time  infused  Weight  Sex 
kg 
9.0  M 
10.2  F 
12.0  M 
9.8  F 
10.0  M 
11.9  M 
15.0  M 
cc 
300 
250 
400 
460 
250 
27O 
450 
Average  ....................................  340 
hrs. 
Permanent 
60 
13 
Permanent 
Group  4  Experiments.  Dogs  Transfused  with  Blood from  Immune  Animals 
Given Second Dose of Endotoxin and Bled Within 24  Hours.--Five  of the 7 re- 
cipient  animals  treated  in  this  manner  survived  the  lethal  dose  of endotoxin 
(Table IV). These animals all reacted more  violently to the endotoxin than did 
those dogs in the group 4  experiments  given reconstituted whole blood contain- W.  W.  SPINK  AND  .].  VICK  505 
ing  preheated  plasma.  However,  hemoconcentration  and  acidosis  were  not 
prominent features in surviving animals. 
Two facts emerge from these observations. First, dogs protected against an 
initial lethal dose of endotoxin survive a  second lethal injection given 1 week 
later. Second, canine blood obtained from immune dogs within 24 hours after a 
second injection of endotoxin affords good protection for normal recipient dogs 
against the lethal effects of endotoxin. 
Group  5  Experiments.  Dogs  Transfused  with  Blood from  Immune  Animals 
Given Second Dose of Endotoxin and Bled 72 Hours Post Endotoxin.--The fore- 
TABLE V 
SutUral Time of Dogs Given Infusion of Whole Blood/tom Immune Animals That Had Survived 
Shock 
Donor blood obtained 72 hours after injection of second dose of endotoxin. 
Amount of blood  Survival time  Dog No.  infused  Weight  Sex 
kg 
10.9  M 
9.0  M 
10.6  M 
6.2  M 
7.9  M 
6.8  M 
6.8  F 
C~ 
250 
250 
380 
250 
375 
275 
450 
15.0 
16.0 
7.5 
4.0 
Permanent 
22.0 
12.0 
Average  ....................................  318  12.7 
going experiments suggested that a booster dose of endotoxin produced an im- 
mune  response  adequate  to  protect  normal  animals  against  a  lethal 
dose of endotoxin.  This protection was demonstrated when donor blood was 
obtained within 24 hours after the booster dose. However, only 1 of 7 dogs sur- 
vived a lethal dose of endotoxin after being transfused with an average of 318 
cc of blood drawn  72  hours  after the  booster dose from the  immune donors 
(Table  V). 
The results in this experiment demonstrate that dogs surviving a lethal dose 
of endotoxin are protected against a second lethal injection of endotoxin. This 
immune state endures  for several months.  However, under  the  experimental 
conditions that were employed there is no evidence that this immunity could 
be passively transferred to other dogs. 
DISCUSSION 
These experiments on canine endotoxin shock have demonstrated that  the 
initial hemodynamic alterations are induced by an interaction between endo- 506  LABILE  SERUM  FACTOR  IN  ENDOTOXIN  SHOCK 
toxin and a labile serum factor. This essential factor is heat-labile, suggesting 
that  an  enzyme or  enzyme system  is  involved.  Previous observations  have 
indicated  that  endotoxin might  activate a  proteolytic enzyme system,  since 
epsilon aminocaproic acid protected dogs against  lethal endotoxin shock (7). 
This compound is an inhibitor of plasminogen activation, and the activation of 
plasminogen is associated with increased proteolytic activity in the serum. 
It is intriguing to consider the possibility that an enzyme participating in 
endotoxin activity might involve complement. Janeway and  Gitlin  (8)  have 
stated that  children with agammaglobulinemia are unusually resistant  to in- 
fections caused by Gram-negative organisms. The devastating effects of these 
bacteria are partly related to the liberation of endotoxin. It has been reported 
in a  child with agammaglobulinemia that the first component of complement 
(C'I)  was considerably reduced, although the hemolytic activity of the com- 
bined four components was normal (9). The first component is considered to be 
of the nature of globulin, and is presumed to exist as a precursor of the enzyme 
esterase. The possible role of complement in endotoxin activity is being explored 
further. 
The present  studies have also focused attention on a  perplexing aspect of 
endotoxin immunity. Dogs surviving a lethal dose of endotoxin are protected 
over a period of several weeks against a second lethal dose of endotoxin. Similar 
observations have been made in mice (10).  Although  a  considerable degree of 
active endotoxin immunity was established in dogs, this immunity could not 
be passively transferred to other dogs under the experimental conditions that 
were employed. However, passive immunity could be established in normal dogs 
against a lethal dose of endotoxin if the dogs were transfused with blood re- 
constituted with preheated plasma,  or transfused with donor blood that had 
been removed from immune dogs within 24 hours after a second dose of endo- 
toxin. In experiments not incorporated within this paper we have also protected 
dogs by infusing them with blood obtained from non-immune donor dogs given 
a sublethal dose of endotoxin within 24 hours before being bled. 
These experiments lead to the hypothesis that in the dog resistance to endo- 
toxin shock can be temporarily induced by the depletion of a serum enzyme or 
enzyme system. This refractory state can be accomplished in the normal dog 
through infusions of blood containing preheated plasma, or by infusion of blood 
obtained from dogs that had been bled within 24 hours after an injection of a 
large dose of endotoxin. It is further postulated that the enzyme system might 
involve complement. This concept of the essential nature  of complement in 
endotoxin shock is supported by the many observations that have been made 
on  the  role  of complement  in  anaphylactic  reactions  and  in  anaphylactoid 
shock. Weil and Spink (2) have pointed out that the pathophysiology of endo- 
toxin  shock  simulates  that  described for anaphylactic  shock.  Schaedler and 
Dubos  (11)  have suggested that an immunologic reaction responsible for the W.  W.  SPINK  AND  J.  VICK  507 
lethal  action of endotoxin is based upon acquired hypersensitivity to  Gram- 
negative bacilli. In support of this are the observations that mice with active 
brucella infection are much more susceptible to the lethal effects of brucella 
endotoxin than non-infected controls (12). 
Our studies on endotoxin shock in several species of animals, including man, 
have clearly indicated the complexity of the problem. From the initial stages 
to either death or recovery there is a constantly changing spectrum of hemody- 
namic and metabolic activity. In an attempt to obtain more precise information 
on the nature  of the  vascular and humoral  changes  that  occur the  "trigger 
mechanism" has been explored in the dog. Similar studies have been made in 
other species, and the results would suggest that the initial vascular alterations 
have a  common mechanism, but the subsequent vascular and tissue changes 
vary considerably. 
SUMMARY 
Peripheral  vascular failure caused by endotoxin in  the  dog has  an  initial 
stage of vasoconstriction. Preliminary studies in vitro  demonstrated that  the 
constriction was due to the interaction of endotoxin with a heat-labile serum or 
plasma factor and platelets, resulting in the liberation of histamine.  Further 
studies on the intact dog support and extend this concept. 
A  standardized dose of Escherichia  coli  endotoxin produced fatal  shock in 
control  adult  mongrel  dogs  within  28  hours.  The  characteristic  pattern 
of changes  included progressive  hypotension, oliguria  and  anuria,  hemocon- 
centration, and acidosis. 
Normal dogs were protected against  endotoxin by transfusions of blood in 
which the essential serum factor was depleted in one of two ways. First, plasma 
separated from the blood of normal animals was heated at 56°C for 30 minutes, 
and the infused reconstituted whole blood protected normal dogs. Protection 
was not afforded by unheated reconstituted blood. Second, blood from immune 
dogs obtained within 24 hours after a second lethal dose of endotoxin protected 
recipient dogs. However, protection was not demonstrated with blood collected 
72 hours after a second injection of endotoxin. 
The nature of the serum factor essential for endotoxin activity is not known. 
It is postulated that an enzyme or enzyme system is involved, and the possible 
role of complement is discussed. 
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